Stock Scorecard
Stock Summary for Jin Medical International Ltd (ZJYL) - $0.13 as of 1/24/2026 11:19:41 AM EST
Total Score
22 out of 30
Safety Score
30 out of 100
Currently on the following lists
Growth Stock List
Tim's Recommendation
Buy
Growth List Algorithm Criteria for ZJYL
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZJYL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZJYL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ZJYL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ZJYL (30 out of 100)
| Stock Price Rating (Max of 10) | 1 |
| Historical Stock Price Rating (Max of 10) | 1 |
| Stock Price Trend (Max of 10) | 0 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 8 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for ZJYL
Financial Details for ZJYL
Company Overview |
|
|---|---|
| Ticker | ZJYL |
| Company Name | Jin Medical International Ltd |
| Country | USA |
| Description | Jin Medical International Ltd. (Ticker: ZJYL) is a prominent designer and manufacturer of advanced mobility solutions, focusing on high-quality wheelchairs and assistive living devices tailored for individuals experiencing mobility challenges. The company is committed to enhancing the quality of life for its users by integrating cutting-edge technology and ergonomic innovations into its products. With a solid emphasis on engineering excellence and user-centered design, Jin Medical is well-positioned to capitalize on growth opportunities in the expanding healthcare sector, reinforcing its role as a significant player in the mobility assistance market. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 1/23/2026 |
Stock Price History |
|
| Last Day Price | 0.13 |
| Price 4 Years Ago | 0.00 |
| Last Day Price Updated | 1/24/2026 11:19:41 AM EST |
| Last Day Volume | 2,425,198 |
| Average Daily Volume | 166,771 |
| 52-Week High | 1.02 |
| 52-Week Low | 0.11 |
| Last Price to 52 Week Low | 18.18% |
Valuation Measures |
|
| Trailing PE | 13.40 |
| Industry PE | 706.98 |
| Sector PE | 128.28 |
| 5-Year Average PE | 0.63 |
| Free Cash Flow Ratio | 1.86 |
| Industry Free Cash Flow Ratio | 40.49 |
| Sector Free Cash Flow Ratio | 35.08 |
| Current Ratio Most Recent Quarter | 2.11 |
| Total Cash Per Share | 0.07 |
| Book Value Per Share Most Recent Quarter | 0.18 |
| Price to Book Ratio | 0.73 |
| Industry Price to Book Ratio | 2.53 |
| Sector Price to Book Ratio | 21.76 |
| Price to Sales Ratio Twelve Trailing Months | 0.92 |
| Industry Price to Sales Ratio Twelve Trailing Months | 90.74 |
| Sector Price to Sales Ratio Twelve Trailing Months | 28.33 |
| Analyst Buy Ratings | N/A |
| Analyst Strong Buy Ratings | N/A |
Share Statistics |
|
| Total Shares Outstanding | 156,547,000 |
| Market Capitalization | 20,351,110 |
| Institutional Ownership | 0.14% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 67.60% |
| Annual Earnings Growth | 27.71% |
| Reported EPS 12 Trailing Months | 0.01 |
| Reported EPS Past Year | 0.35 |
| Reported EPS Prior Year | 0.15 |
| Net Income Twelve Trailing Months | 1,703,818 |
| Net Income Past Year | 3,675,927 |
| Net Income Prior Year | 2,878,230 |
| Quarterly Revenue Growth YOY | -6.40% |
| 5-Year Revenue Growth | 2.90% |
| Operating Margin Twelve Trailing Months | -4.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 11,131,890 |
| Total Cash Past Year | 8,136,179 |
| Total Cash Prior Year | 6,929,508 |
| Net Cash Position Most Recent Quarter | 11,131,890 |
| Net Cash Position Past Year | 8,136,179 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 28,815,184 |
| Total Stockholder Equity Prior Year | 23,979,105 |
| Total Stockholder Equity Most Recent Quarter | 27,912,550 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 3,546,264 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.02 |
| Free Cash Flow Past Year | -2,331,537 |
| Free Cash Flow Prior Year | 2,992,466 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | False |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.03 |
| MACD Signal | -0.02 |
| 20-Day Bollinger Lower Band | 0.02 |
| 20-Day Bollinger Middle Band | 0.32 |
| 20-Day Bollinger Upper Band | 0.62 |
| Beta | 9.46 |
| RSI | 30.38 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 1/24/2026 11:20:27 AM EST |